Insulin resistance, hyperinsulinemia, elevated levels of IGF-1, inflammation, increased sex hormones bioavailability and hyperglycemia are considered to be responsible for increased cancer risk in obese individuals [53]. This evidence concerns the gene IGF1 and hyperinsulinism.